Eduardo Cerello Chapchap
Overview
Explore the profile of Eduardo Cerello Chapchap including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
17
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
da Silva D, Duarte B, de Oliveira Y, Piaia C, Aragao J, Chapchap E, et al.
Clin Lymphoma Myeloma Leuk
. 2024 Dec;
PMID: 39643564
Background: T-cell acute lymphoblastic leukemia (T-ALL) remains understudied compared to B-cell ALL, especially in Latin America. Different biology and response to chemotherapy have been described. Methods: This retrospective multi-site cohort...
2.
Chapchap E, Melo N, Martins D, Lee M, Hamerschlak N
Hematol Transfus Cell Ther
. 2024 Aug;
46 Suppl 6:S182-S192.
PMID: 39129098
Introduction: The scenario of adult patients with acute lymphoblastic leukemia treated in Brazil has not been well described yet. Methods: Four hundred patients diagnosed with acute lymphoblastic leukemia from 1981...
3.
Chapchap E, Silva M, Baroni R, Araujo A, de Assis R, Loggetto S, et al.
Hematol Transfus Cell Ther
. 2023 Sep;
46 Suppl 5:S143-S151.
PMID: 37690980
Introduction: Despite knowledge advances on extramedullary haematopoiesis (EMH) in thalassemic patients, the real picture remains an open issue. Objectives: To assess EMH prevalence in patients with thalassemia major (TM) and...
4.
Chapchap E, Petrucelli Doher M, Kerbauy L, Belucci T, Souza Santos F, Ribeiro A, et al.
Hematol Transfus Cell Ther
. 2022 Jun;
45(3):297-305.
PMID: 35668027
Introduction: Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) patients are exposed to acute and chronic nephrotoxic events (drugs, hypotension, infections, and microangiopathy). The need for hemodialysis (HD) may be associated with...
5.
Chapchap E, Silva M, de Assis R, Kerbauy L, Diniz M, Rosemberg L, et al.
Hematol Transfus Cell Ther
. 2021 Jun;
45(1):7-15.
PMID: 34090847
Introduction: Magnetic resonance imaging (MRI) T2* technique is used to assess iron overload in the heart, liver and pancreas of thalassaemic patients. Optimal iron chelation and expected tissue iron response...
6.
Ribera J, Garcia O, Chapchap E, Gil C, Gonzalez-Campos J, Barba P, et al.
Clin Lymphoma Myeloma Leuk
. 2020 Apr;
20(8):e513-e522.
PMID: 32336676
Background: The treatment of acute lymphoblastic leukemia (ALL) in older adults and elderly patients is a challenge, and modern protocols include targeted therapy and immunotherapy in combination with attenuated or...
7.
Chapchap E, Kerbauy L, Esteves I, Belucci T, Rodrigues M, Kerbauy F, et al.
Eur J Cancer Care (Engl)
. 2019 Jul;
28(5):e13122.
PMID: 31257689
Objectives: To analyse clinical outcomes comparing two age groups of patients undergoing allogeneic haematopoietic stem cell transplantation (allo-HSCT), and to identify risk factors associated with older patients' mortality. Methods: In...
8.
Kerbauy L, Kerbauy M, Bautzer V, Chapchap E, de Mattos V, Rocha J, et al.
Transpl Infect Dis
. 2019 May;
21(5):e13101.
PMID: 31054192
Background: BK polyomavirus reactivation can occur following allogeneic hematopoietic stem cell transplantation (allo-HSCT) and may lead to hemorrhagic cystitis (BKPyV-HC). We hypothesized that development of BKPyV-HC is associated with increased...